Found: 8
Select item for more details and to access through your institution.
PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Toward e‐Scales: Digital Administration of the International Parkinson and Movement Disorder Society Rating Scales.
- Published in:
- Movement Disorders Clinical Practice, 2021, v. 8, n. 2, p. 208, doi. 10.1002/mdc3.13135
- By:
- Publication type:
- Article
Data Analytics from Enroll- HD, a Global Clinical Research Platform for Huntington's Disease.
- Published in:
- Movement Disorders Clinical Practice, 2017, v. 4, n. 2, p. 212, doi. 10.1002/mdc3.12388
- By:
- Publication type:
- Article
Utility of Huntington's Disease Assessments by Disease Stage: Floor/Ceiling Effects.
- Published in:
- Frontiers in Neurology, 2021, v. 12, p. 1, doi. 10.3389/fneur.2021.595679
- By:
- Publication type:
- Article
Modification of PDGFα receptor expression or function alters the metastatic phenotype of 3LL cells.
- Published in:
- Oncogene, 1997, v. 15, n. 13, p. 1545, doi. 10.1038/sj.onc.1201321
- By:
- Publication type:
- Article
PET Molecular Imaging of Phosphodiesterase 10A: An Early Biomarker of Huntington's Disease Progression.
- Published in:
- Movement Disorders, 2020, v. 35, n. 4, p. 606, doi. 10.1002/mds.27963
- By:
- Publication type:
- Article
Long-term effects of rasagiline and the natural history of treated Parkinson's disease.
- Published in:
- 2016
- By:
- Publication type:
- journal article
Long-term outcome of early versus delayed rasagiline treatment in early Parkinson's disease.
- Published in:
- Movement Disorders, 2009, v. 24, n. 4, p. 564, doi. 10.1002/mds.22402
- By:
- Publication type:
- Article